CAH

(redirected from Chronic active hepatitis)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to Chronic active hepatitis: hepatitis, Chronic Persistent Hepatitis

CAH

(Critical Access Hospital) See healthcare IT.
References in periodicals archive ?
Matrix metal loproteinases in liver and serum in chronic active hepatitis C and HCV-induced cirrhosis.
According to a recent study, virtually everyone infected with HCV may become a carrier, and up to 40% of carriers will eventually develop chronic active hepatitis, which may proceed to life-threatening illnesses.
Autoimmune diseases include multiple sclerosis, juvenile diabetes, scleroderma, lupus, rheumatoid arthritis, and chronic active hepatitis.
Later this year PDL expects to begin a Phase II trial with the SMART(TM) M195 Antibody for myeloid leukemia, a Phase II trial with the Human Anti-Hepatitis B Antibody for chronic active hepatitis B, and a Phase II/III trial with the Human Anti-Cytomegalovirus Antibody in AIDS patients with CMV retinitis.
3 percent price cut, effective April 1, for the company's INTRON A alpha interferon, used in the treatment of chronic active hepatitis C.
Engelhardt also reported that the protocols for a planned Phase 2 randomized double blind study of Enzo's oral protein medicine, EHT899, for hepatitis B-associated chronic active hepatitis are being finalized.
PDL) (NASDAQ: PDLI) and an academic collaborator today reported results of a Phase I/II clinical trial with its human antibody for the treatment of chronic active hepatitis B infection.
NYSE:ENZ), encouraged by results thus far of its Phase 2 study of EHT899, the Company's proprietary medicine for treating patients suffering from chronic active hepatitis associated with hepatitis B virus ("HBV"), said it is planning to launch a multi-centered, double blind, randomized study of the product.
NYSE: ICN) today announced that two highly respected pharmaceutical industry professionals have joined two of its operating units to support plans for continued worldwide expansion of the antiviral Virazole (ribavirin), including a potential new indication for chronic active hepatitis C now under development.
NYSE: ENZ) today reported preliminary results of its Phase II clinical trial of EHT899, the Company's proprietary medicine for treating patients suffering from chronic active hepatitis associated with hepatitis B virus ("HBV").
AMEX: VRA) said today it continued to significantly invest in increased research and development programs in the third quarter of 1993, including investment behind Phase III clinical trials of its proprietary antiviral ribavirin (Virazole) against chronic active hepatitis C.
OXO Chemie AG announces the initiation of Phase 2 clinical trials of their macrophage-regulating drug, MACROKINE(R) (WF10), in patients with chronic active hepatitis C virus (HCV) disease.

Full browser ?